Hosted on MSN1mon
TELO Treatment Amazes in Preclinical TrialTelomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results